This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_MALE_GENITAL_NOS_EXALLC for full statistics.
Carcinoma in situ of other/unspecified male genital organs
CD2_INSITU_MALE_GENITAL_NOS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule
Sex
only males
189303
Check conditions None
189303
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D07.6&
Hospital discharge: ICD-9
2336
Cause of death: ICD-10
D07.6&
Cause of death: ICD-9
2336
2 out of 7 registries used, show all original rules.
10
Check minimum number of events None
10
Include endpoints None
10
Remove individuals based on genotype QC
9
CD2_INSITU_MALE_GENITAL_NOS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ organorum genitalium masculinorum aliorum sive non specificatorum
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other/unspecified male genital organs
based on the number of shared cases.
Broader endpoints:
- Carcinoma in situ of other/unspecified male genital organs (controls excluding all cancers)
- In situ neoplasms (controls excluding all cancers)
- In situ neoplasms
- Neoplasms
- External causes of morbidity and mortality
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9 | - | 9 |
| Unadjusted prevalence (%) | 0.00 | - | 0.00 |
| Mean age at first event (years) | 67.36 | - | 67.36 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_MALE_GENITAL_NOS – Carcinoma in situ of other/unspecified male genital organs
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Carcinoma in situ of other/unspecified male genital organs
↥Endpoint not on priority list, no data to show.